Status:

RECRUITING

Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders

Lead Sponsor:

University Hospital, Ghent

Conditions:

Ovarian Reserve

Poor Responders

Eligibility:

FEMALE

18-44 years

Phase:

PHASE4

Brief Summary

This is a prospective, randomized, single center, phase 4 controlled trial. The study will compare the efficacy of two different strategies for the management of predicted poor response patients under...

Eligibility Criteria

Inclusion

  • Informed consent form (ICF) dated and signed.
  • Age ≥18 and \<45 years old.
  • Body Mass Index (BMI) ≥18.5 Kg/m² and \<35 Kg/m².
  • Regular menstrual cycles (between 21 and 35 days).
  • Two ovaries present.
  • Current pregnancy wish.
  • Poor responders as defined according to the POSEIDON criteria:
  • POSEIDON Group 3: patients \< 35 years with poor ovarian reserve pre-stimulation parameters (AFC \<5 or AMH \<1.2 ng/mL); POSEIDON Group 4: patients ≥35 years with poor ovarian reserve pre-stimulation parameters (AFC \<5 or AMH \<1.2 ng/mL).

Exclusion

  • Simultaneous participation in another clinical study.
  • Untreated and uncontrolled thyroid dysfunction.
  • Tumors of the ovary, breast, uterus, pituitary or hypothalamus.
  • Abnormal (not menstrual) vaginal bleeding without a known/diagnosed cause.
  • Ovarian cysts or enlarged ovaries.
  • Malformations of the reproductive organs.
  • Current use of oral contraceptives, anti-psychotics, anti-epileptics or chemotherapy.
  • Previous antibiotic hypersensitivity reactions (streptomycin and/or neomycin).
  • Patients who undergo preimplantation genetic testing (PGT), fertility preservation or oocyte donation.

Key Trial Info

Start Date :

January 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

208 Patients enrolled

Trial Details

Trial ID

NCT04487925

Start Date

January 25 2022

End Date

December 31 2024

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Ghent

Ghent, Belgium, 9000